This would suggest an independent role (possibly through fibrosis) for FCN2 in CKD progression beyond that previously described regarding lectin pathway/primary complement-mediated glomerular disease, such as immunoglobulin A nephropathy [44]. Here, FCN2 is linked to chronic kidney disease.